Glaukos Corporation (GKOS) Financials
GKOS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 920.5 million | 238.0 million |
| March 31, 2026 | 893.3 million | 222.4 million |
| Dec. 31, 2025 | 893.5 million | 237.3 million |
| Sept. 30, 2025 | 999.4 million | 229.8 million |
GKOS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 12.1 million | 28.9 million |
| March 31, 2026 | -16.5 million | 19.1 million |
| Dec. 31, 2025 | 3.9 million | 17.3 million |
| Sept. 30, 2025 | -11.7 million | 14.9 million |
GKOS Net Income
No data available :(
GKOS Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 286.2 million | 102.8 million | 102.8 million |
| March 31, 2026 | 276.7 million | 103.1 million | 103.1 million |
| Dec. 31, 2025 | 278.8 million | 35.8 million | 103.9 million |
| Sept. 30, 2025 | 273.7 million | - | 104.3 million |
GKOS Shares Outstanding
GKOS Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 2.7 million | 51.3 million | 116.1 million | - |
| March 31, 2026 | 4.0 million | 44.1 million | 92.9 million | - |
| Dec. 31, 2025 | 2.9 million | 43.7 million | 94.7 million | - |
| Sept. 30, 2025 | 1.6 million | 38.1 million | 83.0 million | - |
GKOS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 185.6 million | 34.0 million |
| March 31, 2026 | 150.6 million | 33.3 million |
| Dec. 31, 2025 | 143.1 million | 31.8 million |
| Sept. 30, 2025 | 133.5 million | 28.8 million |
GKOS Revenue by Segment
Graph available only for paid members. Upgrade to see it.
GKOS
Price: $184.53
52 week price:
Earnings Per Share: -3.35 USD
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 62314
Ebitda: 2.3 millionMarket Capitalization: 10.1 billion